Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
138 <strong>Annual</strong> Financial Statement Konzern-Jahresabschluss<br />
4.5. Inventories<br />
Value adjustments amounting to KEUR 151 (previous year: KEUR 311) have been made for aging inventories.<br />
These adjustments are included in the cost of sales position of the income statement.<br />
Inventories June 30, <strong>2010</strong><br />
K Euro<br />
June 30, <strong>2009</strong><br />
K Euro<br />
<strong>biolitec</strong> Pharma Ireland 1,555 2,117<br />
<strong>biolitec</strong> USA 3,346 3,944<br />
<strong>biolitec</strong> Malaysia 744 719<br />
CO 7,521 8,785<br />
CO USA 721 539<br />
<strong>biolitec</strong> <strong>AG</strong> 298 1,921<br />
Biolitec SIA 744 863<br />
Others 1,643 276<br />
4.6. Trade accounts receivable<br />
Trade accounts receivable June 30, <strong>2010</strong><br />
Euro<br />
16,572 19,164<br />
June 30, <strong>2009</strong><br />
Euro<br />
Trade accounts receivable 9,063,304 8,810,851<br />
Bad debt allowances (300,000) (45,023)<br />
8,763,304 8,765,828<br />
Receivables are valued depending on their aging structure taking into account all recognizable risks.<br />
An allowance will be made when objective evidence exists that the amount will not be provided for<br />
completely (e.g. an increased possibility for an insolvency of a debtor or severe financial problems of a<br />
debtor). Furthermore, overall value corrections will be made based on the company’s past experiences<br />
with real deficit in payments.<br />
All trade accounts receivables have maturities of up to one year.
Change language